Carlsquare
Carlsquare understands the challenges of high-growth companies, and the dynamics and transformation processes in innovative industries. As an active market participant, they help to shape this landscape. The firm identifies three items – the right timing, the right partner, and the right deal design – as necessary for a successful transaction. They advise not only in connection with the transaction, but also before the transaction – sometimes even years before – and years afterwards. With their expertise in M&A, growth equity and IPOs/equity capital markets, they can utilise the full range of relevant options.
Capital Clarity, founded in 2019 in San Francisco, was an independent investment banking firm specializing in technology, software, and healthcare IT sectors. The team, comprised of former bankers from notable firms, executed numerous mergers and acquisitions, financings, and other strategic transactions totaling over $100 billion. They provided tailored strategic and financial advice to growth companies, focusing on services such as mergers and acquisitions, divestitures, capital raising, and private placements. In April 2023, Capital Clarity was acquired by Carlsquare, marking a significant development in its trajectory.
Centric Advisors Ltd is a corporate finance company based in London, specializing in consumer and retail sectors, particularly for mid-market companies and family-owned businesses in the United Kingdom. Established in 2016, the firm focuses on delivering independent and tailored financial advice, addressing the needs of clients who often find conventional services from larger banks inadequate. Centric Advisors provides a range of strategic advisory services, including capital raising and mergers and acquisitions advisory. The company operates with small teams that engage closely with clients to gain a thorough understanding of their businesses and the unique requirements of their shareholders. Since June 2018, Centric Advisors has functioned as a subsidiary of CatCap GmbH.
Microstim GmbH specializes in developing implantable myostimulators aimed at providing tissue maintenance and functional support for the heart. The company focuses on advanced microcontroller technology for the acquisition and processing of data, as well as the control of cardiac and muscle stimulation impulses. Its innovative devices facilitate wireless communication within the body, enhancing patient monitoring and care. The myostimulators are designed to assist muscle-powered cardiac functions, allowing patients to monitor stimulation levels and preventing overstimulation that could jeopardize therapy. Microstim GmbH gained recognition for its business model by winning a national business plan contest in 2008, highlighting its potential in the medical technology sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.